iHuman (NYSE:IH – Get Free Report) and PLAYSTUDIOS (NASDAQ:MYPS – Get Free Report) are both small-cap communication services companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, profitability, analyst recommendations, institutional ownership and valuation.
Valuation & Earnings
This table compares iHuman and PLAYSTUDIOS”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| iHuman | $744.09 million | 0.08 | $13.64 million | $0.06 | 19.33 |
| PLAYSTUDIOS | $226.45 million | 0.21 | -$28.64 million | ($3.60) | -1.10 |
iHuman has higher revenue and earnings than PLAYSTUDIOS. PLAYSTUDIOS is trading at a lower price-to-earnings ratio than iHuman, indicating that it is currently the more affordable of the two stocks.
Volatility & Risk
iHuman has a beta of 0.04, suggesting that its share price is 96% less volatile than the S&P 500. Comparatively, PLAYSTUDIOS has a beta of 0.96, suggesting that its share price is 4% less volatile than the S&P 500.
Insider & Institutional Ownership
4.9% of iHuman shares are held by institutional investors. Comparatively, 37.5% of PLAYSTUDIOS shares are held by institutional investors. 63.6% of iHuman shares are held by insiders. Comparatively, 14.9% of PLAYSTUDIOS shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Profitability
This table compares iHuman and PLAYSTUDIOS’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| iHuman | 3.06% | 2.44% | 1.73% |
| PLAYSTUDIOS | -20.65% | -19.61% | -15.33% |
Analyst Ratings
This is a breakdown of current recommendations and price targets for iHuman and PLAYSTUDIOS, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| iHuman | 1 | 0 | 0 | 0 | 1.00 |
| PLAYSTUDIOS | 1 | 2 | 1 | 0 | 2.00 |
PLAYSTUDIOS has a consensus price target of $12.50, suggesting a potential upside of 215.66%. Given PLAYSTUDIOS’s stronger consensus rating and higher possible upside, analysts plainly believe PLAYSTUDIOS is more favorable than iHuman.
Summary
iHuman beats PLAYSTUDIOS on 8 of the 14 factors compared between the two stocks.
About iHuman
iHuman Inc. provides intellectual development products to individual users, kindergartens, and distributors in the People’s Republic of China. The company offers interactive and self-directed learning apps, including iHuman Chinese, iHuman ABC, iHuman Pinyin, iHuman Magic Thinking, iHuman Books, iHuman Stories, iHuman Reading, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, iHuman Writing, iHuman Fantastic Friends, and iHuman Readers; bekids Coding, bekids Coloring, bekids Reading, bekids Puzzle, bekids Academy, and Gogo Town; and Aha World, an open-ended interactive app that nurtures a desire for discovery. It provides intellectually stimulating materials, including books, interactive materials, and smart devices that develop children’s abilities in speaking, critical thinking, independent reading, and creativity. iHuman Inc. was founded in 1996 and is based in Beijing, the People’s Republic of China.
About PLAYSTUDIOS
PLAYSTUDIOS, Inc. develops and publishes free-to-play casual games for mobile and social platforms in the United States and internationally. The company's game portfolio includes a diverse range of titles comprising social casino, card, puzzle, and adventure games. It also offers POP! Slots, myVEGAS Slots, my KONAMI Slots, MGM Slots Live, myVEGAS Blackjack, myVEGAS Bingo, Tetris, Solitaire, Spider Solitaire, Jumbline 2, Sudoku, and Mahjong games. PLAYSTUDIOS, Inc. is headquartered in Las Vegas, Nevada.
Receive News & Ratings for iHuman Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iHuman and related companies with MarketBeat.com's FREE daily email newsletter.
